BERNARDINI, N.; SKROZA, N.; ROSSI, G.; MAMBRIN, A.; TOLINO, E.; MARRAFFA, F.; CAVIGLIA, M.; DI GUARDO, A.; VOLPE, S.; PROIETTI, I.; POTENZA, C. Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema. Dermatology Reports, [S. l.], v. 14, n. 4, 2022. DOI: 10.4081/dr.2022.9447. Disponível em: https://www.pagepress.org/journals/dr/article/view/9447. Acesso em: 18 may. 2024.